In this episode, Peter explores the complex and often misunderstood world of genetic testing, building a practical framework for understanding what these tests can and cannot actually tell us about health and disease. He explains why some genetic findings can be genuinely life-changing while many others offer information that is far more probabilistic than deterministic, and why directly measuring the phenotype is often more valuable than inferring risk from DNA alone. Peter examines where genetics can provide meaningful insight across the major disease categories and where its predictive power is far more limited than many people assume. He also discusses how to think critically about different types of genetic tests, how to interpret results in the proper context, and how to avoid the common trap of accumulating more genetic information without gaining greater clarity or actionable insight.
Subscribe on: APPLE PODCASTS | SPOTIFY | RSS | OVERCAST
“My mission for The Peter Attia Drive has always been to provide you with the most rigorous, evidence-informed insights on longevity. To do that without cluttering your experience with ads, we rely entirely on our premium members. If you’d like to support the work that makes this mission possible, consider becoming a premium member.”
– Peter
We discuss:
- Genetic testing: understanding what it can reveal, where it falls short, and how to think about its clinical value [1:45];
- The Human Genome Project: why decoding DNA did not immediately unlock the mysteries of disease [4:15];
- The limitations of genetic testing: probabilistic risk, interpretive uncertainty, and the importance of phenotype [9:30];
- Questions to ask when considering genetic testing [15:45];
- Genetic testing in cardiovascular and metabolic disease: when genotype adds value beyond phenotype [17:00];
- Genetic testing for inherited cardiac conditions: identifying hidden risk beyond routine screening [21:45];
- Genetic testing for cancer risk: inherited syndromes, clinical utility, and the limits of consumer testing [24:00];
- Genetic testing for neurodegenerative disease: risk prediction, planning, and the challenge of limited actionability [28:45];
- Functional medicine genetic testing: the gap between biological plausibility and clinical evidence, and the supplement protocols that aren’t supported by evidence [32:45];
- Pharmacogenetics: using genetic testing to guide medication selection and safety [38:45];
- A framework for evaluating genetic tests according to effect size and clinical actionability [41:45];
- The major types of genetic tests, and how each should be matched to the clinical question being asked [43:30];
- Interpreting genetic test results: choosing the right testing laboratory and understanding what the findings actually mean [49:45];
- Framework summary: why genetic testing is most valuable when it is guided by a clear question, matched with the appropriate test, and capable of meaningfully influencing decisions [56:45]; and
- More.
Show Notes
Genetic testing: understanding what it can reveal, where it falls short, and how to think about its clinical value [1:45]
Recently a patient asked, “Should I be doing genetic testing?”
- It sounds like a simple question, but in reality, it doesn’t tell you very much because the question can mean a lot of different things
- It could mean:
- I’m worried about my risk of Alzheimer’s disease–should we test for APOE genotype?
- It could mean my mother died of breast cancer–should I find out whether or not I carry a BRCA mutation
- It could mean, will genetic testing help determine the best medication to address my lipids?
- Or more commonly, it means something much broader: What diseases am I most likely to get?
- That last question is really what most people have in mind, and Peter understands why
“The notion that your DNA might serve as the kind of blueprint for your future health, that if you could read it closely enough, it would tell you what problems are coming and what to do about them.”‒ Peter Attia
- That is an extraordinarily compelling idea
If we truly had a test that could reliably tell you which diseases you were most likely to develop and exactly how to prevent them, that would be a genuine game changer for medicine
- That promise (or at least some version of that promise) is what many companies have tried to sell
- Genetic testing has been marketed as a way to tell you everything from what diet you should eat, to how you should exercise, to which supplements you need, to how well your body handles things like detoxification or methylation
But this is where we have to slow down and be much more precise, because that’s not quite the reality we live in
Where genetic testing can be useful and where is is not useful
- Genetic testing can absolutely be useful
- In some cases, it can be very useful, even life altering
- There are situations where it can meaningfully change screening, influence treatment decisions, clarify risk, or provide critical information for family members
- But there are also many situations where it adds very little, where it’s oversold
- Or where the better answers come not from genetics at all, but from directly measuring the phenotype through blood work, imaging, family history, or other clinical evaluation
- So the real question is NOT simply, “Should I do genetic testing?”
The real questions are
- What exactly am I trying to learn and is genetic testing the best tool to answer that?
- If so, what kind of test is actually appropriate?
- If I get an answer, will it change anything meaningful about what I do next?
The Human Genome Project: why decoding DNA did not immediately unlock the mysteries of disease [4:15]
- Before getting into where genetic testing is useful and where it’s not, it’s worth stepping back for a moment and talking a bit about the history
- Because many of the assumptions people still carry about what genetic testing can deliver are leftovers from an earlier era
- We now live in a world where sequencing a human genome feels almost routine
- It’s far less expensive than it used to be
- It’s increasingly accessible
- It’s technically much easier to obtain
- But that normalization obscures how recent this capability actually is
The first draft of the human genome was published in 2001
The human genome project was declared essentially complete in 2003
{end of show notes preview}
Would you like access to extensive show notes and references for this podcast (and more)?
Check out this post to see an example of what the substantial show notes look like. Become a member today to get access.
